Abstract
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induce hyperglycemia and the onset of type 2 diabetes, whereas the other group was given an 
Glucose tolerance test (GTT) and insulin tolerance test (ITT)
To evaluate glucose tolerance, mice were given an i.p. injection of D-glucose (1.5 g/kg) 130 after an overnight fast (12 h) with free access to water. Venous blood was collected 30 min 131 before the injection of glucose (time 0), as well as 15, 30, 60, and 120 min after injection 132 from the tail of each mouse, and glucose levels were measured using a OneTouch SureStep 
Measuring serum and renal lipid profiles

144
Mice were sacrificed after anesthetized, and blood was collected by cardiac puncture and 145 centrifuged at 2,000 × g for 20 min at 4°C to prepare plasma. Plasma triglycerides (TG), total 146 cholesterol (CHO), high-density lipoprotein (HDL)-cholesterol, and low-density lipoprotein
147
(LDL)-cholesterol levels were determined using an Olympus Au800 automatic biochemical 148 analyzer (Olympus, Japan).
149
To measure TG and free fatty acid (FFA) contents in the kidney, ~80 mg of kidney tissue 150 from each mouse was homogenized in 250 μL of buffer containing 150 mM NaCl and 10 mM 151 Tris (pH 7.5), and then extracted using 200 μL of methanol and 400 μL of chloroform, as 152 described by Bligh and Dyer (6) . The rest of the procedure was same as that described above 153 using an Olympus Au800 automatic biochemical analyzer (Olympus).
154
Total protein extraction and western blotting 155 Renal tissues were homogenized in lysis buffer (Santa Cruz Biotechnology, Santa Cruz, 156 CA, USA) and the supernatants were collected by centrifugation at 12,000 × g and 4°C. After 8 SDS-polyacrylamide gel electrophoresis and then transferred to nitrocellulose membranes.
159
After blocking with non-fat milk for 1 h at room temperature, the membranes were incubated 160 overnight at 4°C with the following primary antibodies: nuclear factor E2-related factor-2
161
(Nrf-2, 1:1000), superoxide dismutase-1 (SOD-1, 1:2000), NAD(P)H:quinone 
167
After three washes in Tris-buffered saline containing 0.05% Tween 20, the membranes were 168 incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h at room 169 temperature. Antigen-antibody complexes were then visualized using an enhanced 170 chemiluminescence kit (Amersham, Piscataway, NJ, USA), and the intensity of the protein 171 bands was quantified using Quantity one software (Version 4.6.2, Bio-Rad, USA).
172
Histological examination
173
Kidney tissues were fixed in 10% formalin at room temperature for 48 h. After 174 dehydration, the tissue blocks were embedded in paraffin and cut into 4-mm-thick sections.
175
They were then stained with hematoxylin and eosin (H&E) for general morphological 176 examination, periodic acid-Schiff (PAS) for glomerulosclerosis evaluation, and Masson's
177
Trichrome staining for interstitial expansion assessment, as described previously (24, 44, 56) .
178
Five different fields were selected randomly from each slice, each containing at least 50 
Assaying lipid oxidation
192
A thiobarbituric acid (TBA) assay was used to measure relative malondialdehyde (MDA)
193
production as an index of lipid peroxidation, as described previously (11). Briefly, tissue for 15 min at 4°C, harvested, transferred to 96-well plates, the optical density was read at 540 199 nm.
200
Statistical analysis
201
Data were collected from nine mice in each group, and the results are presented as 202 means ± standard error of the mean (SEM). Statistical analyses were performed using 203 one-way or two-way analysis of variance (ANOVA), followed by post-hoc multiple 204 comparisons using Bonferroni's tests. All analyses were performed using GraphPad Prism 5.0
205
(GraphPad Software, San Diego, CA, USA). Statistical significance was defined as P < 0.05.
207
Results
208
Type 2 diabetic mouse model 209 Clinically, the major features of type 2 diabetes are insulin resistance together with 210 obesity, hyperlipidemia, and hyperglycemia. Therefore, in the current study mice were fed a 211 HFD to induce obesity, hyperlipidemia, and insulin resistance, and were then treated using a 212 single injection of STZ to induce hyperglycemia and establish a model of type 2 diabetes. As 213 shown in Fig. 1 , there was a significant increase in their body-weight starting 4 weeks after 214 HFD feeding compared with SD feeding (Con), and the difference between two groups 215 increased gradually in a time-dependent manner (Fig. 1A) . In the GTT, the blood glucose 216 level in the HFD-fed mice after glucose infusion was greater than that in the SD-fed mice at 217 30 min, suggesting that the HFD-fed mice were glucose intolerant (Fig. 1B) . In addition, the 218 blood glucose level in the HFD-fed mice remained higher than did that in the SD-fed mice 219 until the final measurement, although there were no statistically significant differences 220 between the two groups (Fig. 1B) . Furthermore, blood glucose levels during the ITT were 221 significant higher in HFD-fed mice than in SD-fed mice at all time points (Fig. 1C) . The 222 above results suggest that the mice fed with a HFD for 12 weeks had already developed significant increase in blood glucose compared with the HFD-fed alone group, but did not 225 induce hyperglycemia compared with the SD-fed (Con) group (Fig. 1D) . Fig. 2A) . Although the blood glucose levels in the combination group were decreased 232 slightly compared with FGF21 treatment alone, the difference was not statistically significant 233 ( Fig. 2A) . In addition, both LDR and FGF21 significantly ameliorated diabetes-induced 234 insulin resistance (Fig. 2B) ; however, the combination treatment improved insulin sensitivity 235 additively compared with either single treatment alone (Fig. 2B ).
236
Effects of the different treatments on renal dysfunction in diabetic mice
237
Diabetes increased the levels of UP and mAlb significantly, indicating the induction of 238 renal dysfunction (Table 1) . However, FGF21 treatment prevented diabetes-induced renal 239 dysfunction significantly, as shown by reduced UP and mAlb and increased U-Cre levels.
240
Exposure to LDR also reduced UP and mAlb significantly, but did not affect U-Cre levels.
241
Renal dysfunction which reflected by increased UP and mAlb levels, was diminished further (Fig. 3A) . These pathological changes were suppressed 251 significantly by LDR or FGF21 treatment alone (Fig. 3A) , and particularly by the 252 combination treatment. Diabetes-induced kidney injury is always associated with renal hypertrophy, which is 266 characterized by an increased kidney weight to tibia length ratio. In the current study, this 267 ratio was increased in the DM group compared with HFD-fed mice group (Fig. 3G) In addition to hyperglycemia, dyslipidemia is a crucial systemic pathogenesis of DN. As 274 shown in Table 2 , hyperlipidemia was evident in the DM groups, as shown by increased 275 plasma TG levels. Consistent with the plasma profiles, kidney tissue H&E staining revealed 276 an increased number of fat vacuoles in the kidney (Fig. 3A) ; the renal TG and FFA levels 277 were also increased significantly in the diabetic mice (Table 2 ). These results suggest that and to an even greater extent by the combination treatment.
294
Effects of the different treatments on the renal expression of antioxidants in diabetic mice 295 Next, we measured the renal expression of multiple antioxidants in treated and untreated 296 diabetic mice. Western blotting revealed that the expression of SOD-1 (Fig. 6A) , NQO-1 (Fig.   297 6B), and HO-1 (Fig. 6C ) was decreased significantly in the kidneys of DM mice and 298 DM/FGF21 mice ( Fig. 6A-C) . Interestingly, exposure to LDR reversed the diabetes-induced 299 suppression of these antioxidants significantly, and the expression of these antioxidants was 300 much higher in the DM/LDR group than in the DM group (Fig. 6A-C) . The expression of the 301 antioxidants was similar in DM/Com and control mice. These results suggest that LDR, but 302 not FGF-21, increased renal antioxidant levels significantly under diabetic conditions.
303
The expression of the abovementioned antioxidants is regulated positively by the 304 transcription factor Nrf2. We demonstrated previously that Nrf2 is upregulated in diabetic 305 mice exposed to LDR (51, 57). Therefore, we next determined whether the altered 306 antioxidant expression in the DM/LDR and DM/Com groups was due to altered renal Nrf2 307 levels (Fig. 6D) . As expected, the pattern of Nrf2 expression was similar to the antioxidant 308 expression in the different groups, suggesting that diabetes downregulated and LDR 309 upregulated renal antioxidant levels mainly by altering Nrf2 expression.
Discussion
313
The kidney is the main target organ of diabetes, which leads to the development of DN.
314
DN is characterized by renal dysfunction and pathological changes such as renal hypertrophy, 315 fibrosis, and glomerulosclerosis (18, 21, 33) . The pathogenesis of DN is highly complex, and 316 is the consequence of both systemic and renal pathogeneses. Therefore, we hypothesized that 317 improving the systemic pathogenesis of diabetes while protecting the kidney from 318 diabetes-induced damage might additively prevent the development of DN.
319
FGF21 is a member of the FGF family that exerts systemic therapeutic effects to 320 improve hyperglycemia, dyslipidemia, and insulin resistance (2, 16). Serum FGF21 levels 321 were increased significantly in humans with both acute and chronic renal dysfunction during 322 early-to end-stage kidney disease, which might be an adaptive response to diabetes to confer 323 protective effects (30). FGF21 suppresses diabetes-induced inflammation, oxidative stress, 324 and fibrosis in multiple organs, which could be attributed to its effects on maintaining glucose 325 and lipid homeostasis and improving insulin resistance (22, 27, 56) . Similarly, renal 326 protective effects of FGF21 were also observed in our recent study performed in an acute 327 lipotoxic model of type 1 diabetes (56).
328
High doses of ionizing radiation (HDR) induce a variety of harmful effects, including 329 acute death and late carcinogenesis. Although LDR was also considered dangerous according 330 to the linear no-threshold (LNT) hypothesis (32), increasing evidence has suggested that 331 LET radiation at dose levels lower than 100 mGy could induce beneficial effects, including 332 extending life span, enhancing immunity, and improving DNA repair (17, 23, 36) .
333
Epidemiological surveys have analyzed individuals exposed to <100 mGy radiation.
Generally, there was (1) no increase or even a reduced risk of the incidence of solid cancer; (2) 335 no increase in the incidence of leukemia; and (3) no increase in cardiovascular diseases (5, 15, 336 28, 31, 37). A study supported by the Radiation Effects Research foundation showed that the 337 dose-response relationship supported the LNT model in principle in the dose range 0-150 338 mGy; however, the dose-response relationship below 100 mGy tends to fluctuate, which 339 limits statistical significance in the increase in the incidence of cancer at lower doses (42).
340
Our recent studies demonstrated that LDR also induces beneficial effects on diabetes and its 341 associated complications (43, 56, 57) . The available data suggest that pre-exposure to LDR 342 reduces the incidence of alloxan-induced diabetes, and also delays the onset of hyperglycemia 343 in diabetes-prone non-obese diabetic mice (46, 48) . This protection is associated with the 344 prevention of oxidative damage (51-53, 57). Our previous study revealed that, in addition to 345 anti-oxidative effects, LDR also prevents inflammation to protect against DN (43, 51, 55, 56) .
346
Patients with DN have poor renal function; however, most drugs used to treat DN are 347 excreted through the kidney, which further increases the renal working load in diabetic 348 patients. Therefore, the use of LDR as a non-invasive approach has been investigated to 349 prevent chronic renal diseases (4, 47). In the present study, we combined LDR and FGF21 as 350 a therapeutic strategy for the first time to explore whether simultaneously blocking the 351 systemic and renal pathogeneses could further prevent the development of DN.
352
We developed a human-like type 2 diabetic model using a HFD/STZ protocol. After the 353 model of type 2 diabetes was established successfully, the mice were exposed to LDR (50 354 mGy/day, every other day for 4 weeks) with and without FGF21 (1.5 mg/kg, daily for 8 355 weeks) based on doses optimized in our previous studies (43).
In the early-stage of DN, some abnormalities are frequently associated with enlarged 357 kidneys. We evaluated renal hypertrophy by calculating the kidney weight to tibia length ratio.
358
The diabetes-induced increase in this ratio was suppressed slightly by LDR and significantly Therefore, it is likely that the additive effects of LDR and FGF21 on insulin sensitivity were 388 due mainly to correction of the abnormal lipid profile.
389
Next, we assessed whether the combination strategy also afforded local renal protection 390 at the cellular and molecular levels, in addition to the abovementioned systemic effects. Large A B C D
